Rapid Molecular Diagnostic Platform

Zyvex Labs LLC is building the next generation Rapid molecular Diagnostics platform using in-house nano-chips and advanced photon optics with DNA hybridization without PCR for detecting and characterizing wide spectrum of biomarkers including microbes, antibiotic resistant bacteria, viruses, plasmids, and fungi. Our technology can detect genetic markers and aberrations of the human genome such as viral infiltration, additional or deletional mutations, and changes in proteomic expressions.

Zyvex Labs has spun-off a new company, Rapid Molecular Diagnostics LLC (http://www.rapidmoleculardiagnostics.com/) to commercialize this technology. We are excited about the prospects of a fast(minutes), inexpensive, and accurate diagnostic tool that can be used to diagnose COVID-19.